What question did this study set out to answer?

The research aims to enhance the efficacy of RAS inhibitors in pancreatic cancer by targeting PIKfyve and exploring strategies to sustain tumor regression.

March 7, 2026Cancer Research

Abstract A019: Enhancing RAS therapies by targeting PIKfyve in pancreatic cancer

View Full Paper

Ask AI

Bookmark

Authors

CCCaleb ChengUniversity of Michigan JWJasmine P. WisniewskiUniversity of Michigan YQYuanyuan QiaoUniversity of Michigan

Discussion

Member takes

Implication

Demonstrates the potential of combining PIKfyve inhibitors with RAS therapies to improve outcomes in pancreatic cancer, suggesting new treatment strategies.

Key Points

The research aims to enhance the efficacy of RAS inhibitors in pancreatic cancer by targeting PIKfyve and exploring strategies to sustain tumor regression.
Evaluated the effect of the PIKfyve inhibitor ESK981 combined with the pan-RAS inhibitor RMC-6236 in syngeneic orthotopic models
Assessed tumor responses and tolerability of combination therapies
Investigated the role of immune checkpoint blockade in enhancing treatment durability
The combination of RMC-6236 and ESK981 is well tolerated and induces complete responses in some models
All tumors eventually regrow after therapy withdrawal, leading to a 2-month survival period
Adding immune checkpoint blockade may boost the anti-tumor immune response and help eliminate residual disease

Cite This Study

Cheng et al. (2026) studied this question.

synapsesocial.com/papers/69abc1a65af8044f7a4ea8a6 https://doi.org/10.1158/1538-7445.rasoncother26-a019

View Full Paper

Ask AI

Bookmark

Implication

Demonstrates the potential of combining PIKfyve inhibitors with RAS therapies to improve outcomes in pancreatic cancer, suggesting new treatment strategies.

Abstract A019: Enhancing RAS therapies by targeting PIKfyve in pancreatic cancer

Discussion

Member takes

Implication

Key Points

Cite This Study

Abstract A019: Enhancing RAS therapies by targeting PIKfyve in pancreatic cancer

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider